Previous studies have shown the value and effectiveness of combining innovative digital adherence monitoring devices and targeted educational interventions by PSP nurses during the course of r-hGH treatment in children with growth disorders (4, 6). This evidence concerns the gene GH1 and hereditary endocrine growth disease.